Core Laboratories N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
12 mei 2014 - 07:42
Statutaire naam
Core Laboratories N.V.
Titel
CORE LAB ISSUES UPDATED GUIDANCE FOR Q2 AND FY 2014
Bericht
Core Laboratories N.V. (NYSE: "CLB US" and NYSE Euronext: "CLB NA") recorded April 2014 operating results below those of March 2014, the Company’s second most profitable March ever, precipitating new second quarter and full year 2014 earnings per share (EPS) guidance. The Company had used encouraging March results, following the weather affected results from February, and improving North American activity levels, in general, to set prior second quarter 2014 guidance and to maintain its prior full year EPS guidance. Although Core continues to expect quarterly sequential improvements in all three segments, due to unexpected disappointing results in April, Core now projects second quarter 2014 EPS guidance in the $1.32 – 1.35 range with revenue ranging from $265,000,000 to $270,000,000, both exceeding last year’s second quarter results. Operating margins are expected to be 30% to 31%. Free cash flow (FCF) is expected to be approximately $65,000,000, an all-time high for any second quarter in Company history.
Datum laatste update: 22 december 2025